| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US5601843 | PFIZER | Pharmaceutical tablet composition |
Feb, 2014
(10 years ago) | |
Arthrotec is owned by Pfizer.
Arthrotec contains Diclofenac Sodium; Misoprostol.
Arthrotec has a total of 1 drug patent out of which 1 drug patent has expired.
Expired drug patents of Arthrotec are:
- US5601843
Arthrotec was authorised for market use on 24 December, 1997.
Arthrotec is available in tablet, delayed release;oral dosage forms.
The generics of Arthrotec are possible to be released after 11 February, 2014.
Drugs and Companies using DICLOFENAC SODIUM; MISOPROSTOL ingredient
Market Authorisation Date: 24 December, 1997
Treatment: NA
Dosage: TABLET, DELAYED RELEASE;ORAL
How can I launch a generic of ARTHROTEC before it's drug patent expiration?
More Information on Dosage
ARTHROTEC family patents
